Analytical methods | |||
---|---|---|---|
Comparative study | #1 | #2 | |
Chromatography | DI | GC | |
Ion source | ESI | EI | |
Positive/Negative mode | positive | – | |
Mass analyzer | Q-TOF | ion trap | |
Identification level | MS/MS | – |
Sample information | |||
---|---|---|---|
Comparative study | #1 | #2 | |
Country | Spain | Spain | |
Specimen | bronchoalveolar lavage fluid | bronchoalveolar lavage fluid | |
Marker function | diagnosis | diagnosis | |
Participants(Case) | Cancer type | lung cancer | lung cancer |
Stage | – | – | |
Number | 24 | 24 | |
Gender (M,F) | 16, 8 | 16, 8 | |
Mean age (range) (M,F) | 66 ± 11 | 66 ± 11 | |
Smoking status | – | – | |
Participants(Control) | Type | noncancerous lung diseases | noncancerous lung diseases |
Number | 31.0 | 31.0 | |
Gender (M,F) | 23, 8 | 23, 8 | |
Mean age (range) (M,F) | 56 ± 13 | 56 ± 13 | |
Smoking status | – | – |
Data processing and metabolite identification | |
---|---|
Data processing software | Markerview |
Database search | HMDB, METLIN |
Statistics and concentration information | |
---|---|
Differential analysis method | PLS-LDA, one-way ANOVA |
Classification method | ROC curve analysis |
Survival analysis method | – |
Metabolite | Comparative study | Author-emphasized biomarkers | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
---|---|---|---|---|---|---|---|---|
benzoic acid | – | – | – | – | 0.21 | 0.048 | – | 1.01 |
urea | – | – | – | – | 0.74 | 0.048 | – | 1.3 |
acetic acid | – | – | – | – | 1.71 | 0.047 | – | 1.93 |
L-aspartate | – | – | – | – | 0.48 | 0.047 | – | 1.35 |
PC(16:0/16:0) | – | – | – | – | 0.6 | 0.047 | – | 1.69 |
phosphoric acid | – | V | – | – | 0.42 | 0.047 | – | 2.12 |
PPE(18:0/20:4) | – | – | – | – | 0.86 | 0.047 | – | 1.24 |
phosphocholine | – | – | – | – | 1.48 | 0.046 | – | 2.09 |
L-serine | – | – | – | – | 0.78 | 0.044 | – | 1.31 |
adenine | – | V | – | – | 1.92 | 0.043 | – | 1.27 |
galactose | – | – | – | – | 0.63 | 0.043 | – | 2.1 |
L-proline | – | – | – | – | 0.68 | 0.042 | – | 1.01 |
pyroglutamate | – | – | – | – | 0.83 | 0.042 | – | 1.01 |
PC(18:1/18:1) | – | – | – | – | 0.8 | 0.041 | – | 1.14 |
L-valine | – | – | – | – | 0.57 | 0.04 | – | 1.87 |
inosine | – | – | – | – | 0.36 | 0.038 | – | 1.02 |
LPC(22:5) | – | – | – | – | 0.68 | 0.038 | – | 1.6 |
L-arginine | – | – | – | – | 0.8 | 0.036 | – | 1.43 |
L-glutamine | – | – | – | – | 0.5 | 0.033 | – | 1.44 |
creatine | – | – | – | – | 0.76 | 0.032 | – | 1.53 |
inosytol | – | – | – | – | 0.63 | 0.028 | – | 1.17 |
PPE(18:1/20:4) | – | – | – | – | 0.86 | 0.028 | – | 1.41 |
acetylcholine | – | – | – | – | 0.61 | 0.027 | – | 1.67 |
LPC(18:2) | – | – | – | – | 0.86 | 0.024 | – | 1.1 |
PE(18:1/18:0) | – | – | – | – | 0.88 | 0.024 | – | 1.36 |
carnitine | – | V | – | – | 0.92 | 0.023 | – | 2.67 |
isocitric acid | – | – | – | – | 0.53 | 0.023 | – | 1.67 |
oleic acid | – | – | – | – | 0.78 | 0.023 | – | 1.45 |
PE(16:0/18:0) | – | – | – | – | 0.9 | 0.023 | – | 1.04 |
stearic acid | – | – | – | – | 1.36 | 0.022 | – | 1.88 |
cholesterol | – | – | – | – | 0.47 | 0.019 | – | 1.55 |
glycerophosphocholine | – | – | – | – | 0.7 | 0.019 | – | 1.14 |
L-glutamate | – | – | – | – | 0.84 | 0.019 | – | 1.58 |
fructose | – | – | – | – | 0.58 | 0.017 | – | 1.66 |
L-glycine | – | – | – | – | 0.6 | 0.017 | – | 1.49 |
choline | – | V | – | – | 0.68 | 0.014 | – | 2.41 |
lactic acid | – | – | – | – | 0.62 | 0.012 | – | 1.96 |
acetylcarnitine | – | – | – | – | 0.71 | 0.011 | – | 1.71 |
palmitic acid | – | – | – | – | 1.37 | 0.008 | – | 2.11 |
PE(18:0/18:0) | – | – | – | – | 0.85 | 0.006 | – | 1.64 |
glycerol | – | V | – | – | 0.59 | 0.004 | – | 2.18 |
LPS(18:0) | – | – | – | – | 0.72 | 0.001 | – | 1.63 |
Metabolite | Comparative study | Author-emphasized biomarkers | Cutoff value | AUROC (95%CI) | Sensitivity (%) | Specificity (%) | Accuracy (%) |
---|---|---|---|---|---|---|---|
benzoic acid | – | – | – | 0.52 | – | – | – |
urea | – | – | – | 0.54 | – | – | – |
acetic acid | – | – | – | 0.52 | – | – | – |
L-aspartate | – | – | – | 0.74 | – | – | – |
PC(16:0/16:0) | – | – | – | 0.56 | – | – | – |
phosphoric acid | – | V | – | 0.79 | – | – | – |
PPE(18:0/20:4) | – | – | – | 0.52 | – | – | – |
phosphocholine | – | – | – | 0.67 | – | – | – |
L-serine | – | – | – | 0.53 | – | – | – |
adenine | – | V | – | 0.82 | – | – | – |
galactose | – | – | – | 0.68 | – | – | – |
L-proline | – | – | – | 0.63 | – | – | – |
pyroglutamate | – | – | – | 0.57 | – | – | – |
PC(18:1/18:1) | – | – | – | 0.51 | – | – | – |
L-valine | – | – | – | 0.66 | – | – | – |
inosine | – | – | – | 0.63 | – | – | – |
LPC(22:5) | – | – | – | 0.61 | – | – | – |
L-arginine | – | – | – | 0.53 | – | – | – |
L-glutamine | – | – | – | 0.66 | – | – | – |
creatine | – | – | – | 0.6 | – | – | – |
inosytol | – | – | – | 0.58 | – | – | – |
PPE(18:1/20:4) | – | – | – | 0.55 | – | – | – |
acetylcholine | – | – | – | 0.57 | – | – | – |
LPC(18:2) | – | – | – | 0.5 | – | – | – |
PE(18:1/18:0) | – | – | – | 0.59 | – | – | – |
carnitine | – | V | – | 0.87 | – | – | – |
isocitric acid | – | – | – | 0.57 | – | – | – |
oleic acid | – | – | – | 0.54 | – | – | – |
PE(16:0/18:0) | – | – | – | 0.59 | – | – | – |
stearic acid | – | – | – | 0.64 | – | – | – |
cholesterol | – | – | – | 0.72 | – | – | – |
glycerophosphocholine | – | – | – | 0.52 | – | – | – |
L-glutamate | – | – | – | 0.51 | – | – | – |
fructose | – | – | – | 0.6 | – | – | – |
L-glycine | – | – | – | 0.74 | – | – | – |
choline | – | V | – | 0.78 | – | – | – |
lactic acid | – | – | – | 0.65 | – | – | – |
acetylcarnitine | – | – | – | 0.71 | – | – | – |
palmitic acid | – | – | – | 0.69 | – | – | – |
PE(18:0/18:0) | – | – | – | 0.56 | – | – | – |
glycerol | – | V | – | 0.88 | – | – | – |
LPS(18:0) | – | – | – | 0.58 | – | – | – |